[
  {
    "ts": null,
    "headline": "Amgen Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Amgen Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=33d31d2f13c6166aeb109039a4da7dd0f17dacb12f365d2043ce029ba9d44035",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746722160,
      "headline": "Amgen Inc. stock underperforms Thursday when compared to competitors",
      "id": 134342369,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=33d31d2f13c6166aeb109039a4da7dd0f17dacb12f365d2043ce029ba9d44035"
    }
  },
  {
    "ts": null,
    "headline": "2 Unstoppable Dividend Stocks to Buy and Hold Forever",
    "summary": "Amgen is an innovative leader in an industry where its products will always be in high demand.  Microsoft is navigating the current situation well and boasts lucrative growth opportunities.  Two excellent options right now are Amgen (NASDAQ: AMGN) and Microsoft (NASDAQ: MSFT).",
    "url": "https://finnhub.io/api/news?id=b5ec77474f3def35cc197535ae13482faf1d14c683b015fdaa3e1f87998ac9b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746712380,
      "headline": "2 Unstoppable Dividend Stocks to Buy and Hold Forever",
      "id": 134325042,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen is an innovative leader in an industry where its products will always be in high demand.  Microsoft is navigating the current situation well and boasts lucrative growth opportunities.  Two excellent options right now are Amgen (NASDAQ: AMGN) and Microsoft (NASDAQ: MSFT).",
      "url": "https://finnhub.io/api/news?id=b5ec77474f3def35cc197535ae13482faf1d14c683b015fdaa3e1f87998ac9b4"
    }
  },
  {
    "ts": null,
    "headline": "BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit",
    "summary": "BeiGene's innovative cancer treatments, Brukinsa and Tevimbra, are driving growth. Click for a look at ONC and its latest earnings results.",
    "url": "https://finnhub.io/api/news?id=ca884ea3d0ae3c3bfb15c378e648089047409c4bd9deeb85e5a87fafa283d5d6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746696282,
      "headline": "BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit",
      "id": 134323621,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1169172518/image_1169172518.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "BeiGene's innovative cancer treatments, Brukinsa and Tevimbra, are driving growth. Click for a look at ONC and its latest earnings results.",
      "url": "https://finnhub.io/api/news?id=ca884ea3d0ae3c3bfb15c378e648089047409c4bd9deeb85e5a87fafa283d5d6"
    }
  }
]